Mirtazapine Tablet
Product Images NDC 71335-0441

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 71335-0441). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

S:\exranbaxy\san-reg\regulatory\spl\deepa\2020\mrtazapine\20191016_f23631be-c7ae-46e9-b771-a70be17bc9f0\mirtazapine-01.jpg (Mirtazapine 01)

Chemical structure of Mirtazapine, showing its fused ring system including a pyridine and multiple nitrogen atoms as part of the heterocyclic framework.*

FDA Label Image

Label (Lbl713350441)

Mirtazapine 30 mg Tablet label from Bryant Ranch Prepack. The label indicates it is a 30 mg strength tablet with an NDC number 71335-0441. It compares to Remeron 30 mg Tablet by Alkaloida Chemical Company Zrt. Storage instructions specify 20°-25°C (68°-77°F), and it includes a caution to keep drugs out of reach of children. Additional label features include lot number 1523487 and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.